Intellectual Property,
Civil Litigation
Oct. 5, 2020
San Diego lawyer wins $235M drug patent verdict
The Delaware case attracted multiple amicus briefs and — if allowed to stand — would have broad implications by making it easy for generic drugmakers to avoid infringement lawsuits.
In a major victory in a patent infringement suit, Fish & Richardson PC litigator Juanita R. Brooks persuaded a federal appellate panel Friday to reinstate a $235.5 million verdict for client GlaxoSmithKline LLC against Teva Pharmaceuticals USA Inc.
A divided U.S. Circuit Court of Appeals panel ruled a Delaware judge was wrong to overturn the verdict in a dispute over a drug called carvedilol that is used to treat high blood pressure ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In